63 related articles for article (PubMed ID: 10979040)
21. Mouse model of male germ cell apoptosis in response to a lack of hormonal stimulation.
Hikim AP; Vera Y; Elhag RI; Lue Y; Cui YG; Pope V; Leung A; Atienza V; Wang C; Swerdloff RS
Indian J Exp Biol; 2005 Nov; 43(11):1048-57. PubMed ID: 16315394
[TBL] [Abstract][Full Text] [Related]
22. Suppressive effects of antiandrogens, finasteride and flutamide on development of prostatic lesions in a transgenic rat model.
Cho YM; Takahashi S; Asamoto M; Suzuki S; Tang M; Shirai T
Prostate Cancer Prostatic Dis; 2007; 10(4):378-83. PubMed ID: 17457304
[TBL] [Abstract][Full Text] [Related]
23. Toremifene prevents prostate cancer in the transgenic adenocarcinoma of mouse prostate model.
Raghow S; Hooshdaran MZ; Katiyar S; Steiner MS
Cancer Res; 2002 Mar; 62(5):1370-6. PubMed ID: 11888907
[TBL] [Abstract][Full Text] [Related]
24. Hair loss in women.
Camacho-Martínez FM
Semin Cutan Med Surg; 2009 Mar; 28(1):19-32. PubMed ID: 19341939
[TBL] [Abstract][Full Text] [Related]
25. Concept evaluation: androgen-stimulated immature intact male rats as an assay for antiandrogens.
Ashby J; Owens W; Lefevre PA
Regul Toxicol Pharmacol; 2002 Apr; 35(2 Pt 1):280-5. PubMed ID: 12052012
[TBL] [Abstract][Full Text] [Related]
26. Effects of antiandrogens on glycogen metabolism of spermatozoa from caput epididymidis.
Panse GT
Indian J Exp Biol; 1981 Sep; 19(9):872-3. PubMed ID: 6458560
[No Abstract] [Full Text] [Related]
27. Effects of antiandrogens on chromatin remodeling and transcription of the integrated mouse mammary tumor virus promoter.
List HJ; Smith CL; Martinez E; Harris VK; Danielsen M; Riegel AT
Exp Cell Res; 2000 Oct; 260(1):160-5. PubMed ID: 11010820
[TBL] [Abstract][Full Text] [Related]
28. Antiandrogen-induced cell death in LNCaP human prostate cancer cells.
Lee EC; Zhan P; Schallhom R; Packman K; Tenniswood M
Cell Death Differ; 2003 Jul; 10(7):761-71. PubMed ID: 12815459
[TBL] [Abstract][Full Text] [Related]
29. NTP Toxicology and Carcinogenesis Studies of 1-Trans-Delta(9)-Tetrahydrocannabinol (CAS No. 1972-08-3) in F344 Rats and B6C3F1 Mice (Gavage Studies).
National Toxicology Program
Natl Toxicol Program Tech Rep Ser; 1996 Nov; 446():1-317. PubMed ID: 12594529
[TBL] [Abstract][Full Text] [Related]
30. Testosterone antagonist (flutamide) blocks ovulation and preovulatory surges of progesterone, luteinizing hormone and oestradiol in laying hens.
Rangel PL; Sharp PJ; Gutierrez CG
Reproduction; 2006 Jun; 131(6):1109-14. PubMed ID: 16735550
[TBL] [Abstract][Full Text] [Related]
31. Is there a role for antiandrogen monotherapy in patients with metastatic prostate cancer?
Kaisary AV; Iversen P; Tyrrell CJ; Carroll K; Morris T
Prostate Cancer Prostatic Dis; 2001; 4(4):196-203. PubMed ID: 12497018
[TBL] [Abstract][Full Text] [Related]
32. Androgen receptor is targeted to distinct subcellular compartments in response to different therapeutic antiandrogens.
Whitaker HC; Hanrahan S; Totty N; Gamble SC; Waxman J; Cato AC; Hurst HC; Bevan CL
Clin Cancer Res; 2004 Nov; 10(21):7392-401. PubMed ID: 15534116
[TBL] [Abstract][Full Text] [Related]
33. Effects of combination therapy with a luteinizing hormone-releasing hormone agonist and chlormadinone acetate on rat prostate weight and plasma testosterone levels.
Gotanda K; Shinbo A; Okada M; Nakano Y; Kobayashi H; Sasaki T; Hagiwara M; Akaza H
Prostate Cancer Prostatic Dis; 2003; 6(1):66-72. PubMed ID: 12664069
[TBL] [Abstract][Full Text] [Related]
34. NTP Toxicology and Carcinogenesis Studies of Salicylazosulfapyridine (CAS No. 599-79-1) in F344/N Rats and B6C3F1 Mice (Gavage Studies).
National Toxicology Program
Natl Toxicol Program Tech Rep Ser; 1997 May; 457():1-327. PubMed ID: 12587019
[TBL] [Abstract][Full Text] [Related]
35. Long-term treatment of familial male-limited precocious puberty (testotoxicosis) with cyproterone acetate or ketoconazole.
Almeida MQ; Brito VN; Lins TS; Guerra-Junior G; de Castro M; Antonini SR; Arnhold IJ; Mendonca BB; Latronico AC
Clin Endocrinol (Oxf); 2008 Jul; 69(1):93-8. PubMed ID: 18088394
[TBL] [Abstract][Full Text] [Related]
36. Metastatic prostate cancer treated by flutamide versus cyproterone acetate. Final analysis of the "European Organization for Research and Treatment of Cancer" (EORTC) Protocol 30892.
Schröder FH; Whelan P; de Reijke TM; Kurth KH; Pavone-Macaluso M; Mattelaer J; van Velthoven RF; Debois M; Collette L;
Eur Urol; 2004 Apr; 45(4):457-64. PubMed ID: 15041109
[TBL] [Abstract][Full Text] [Related]
37. NTP Toxicology and Carcinogenesis Studies of alpha-Methyldopa Sesquihydrate (CAS No. 41372-08-1) in F344/N Rats and B6C3F1 Mice (Feed Studies).
National Toxicology Program
Natl Toxicol Program Tech Rep Ser; 1989 Mar; 348():1-184. PubMed ID: 12704436
[TBL] [Abstract][Full Text] [Related]
38. Comparison of the clinical efficacy of flutamide and spironolactone plus ethinyloestradiol/cyproterone acetate in the treatment of hirsutism: a randomised controlled study.
Karakurt F; Sahin I; Güler S; Demirbas B; Culha C; Serter R; Aral Y; Bavbek N
Adv Ther; 2008 Apr; 25(4):321-8. PubMed ID: 18389188
[TBL] [Abstract][Full Text] [Related]
39. NTP Toxicology and Carcinogenesis Studies of o-Benzyl-p-Chlorophenol (CAS No. 120-32-1) in F344/N Rats and B6C3F1 Mice (Gavage Studies).
National Toxicology Program
Natl Toxicol Program Tech Rep Ser; 1994 Jan; 424():1-304. PubMed ID: 12616287
[TBL] [Abstract][Full Text] [Related]
40. NTP Toxicology and Carcinogenesis Studies of Phenolphthalein (CAS No. 77-09-8) in F344/N Rats and B6C3F1 Mice (Feed Studies).
National Toxicology Program
Natl Toxicol Program Tech Rep Ser; 1996 Nov; 465():1-354. PubMed ID: 12579199
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
